We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Chronic Obstructive Pulmonary Disease (COPD) Market Analysis 2022: Industry Size, Share, Emerging Trends, Growth Opportunities and Forecast to 2028




 

The Chronic Obstructive Pulmonary Disease (COPD) Market is set to witness immense growth during the forecast period 2022-2028. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/players/vendors analysis, segments & sub-segments, and forecast. The report also focuses on market drivers, challenges (current and future), revenue growth, future roadmap, standardization, deployment models, and forecast analysis.

Overview:

Chronic obstructive pulmonary disease (COPD) is a progressive condition characterized by limited airflow to the lungs. Over 15 million people in the United States suffer from COPD, and many more don't know they have the condition. Women make up more than half of the population, and it is the fourth-leading cause of death and disability in the world. However, while the exact cause is unknown, smoking is a major contributor. Although there is no cure for chronic obstructive pulmonary disease (COPD), a variety of treatments and lifestyle changes can slow its progression and improve your quality of life. Stopping smoking, for example, is the best way to prevent the disease from progressing. Other treatments may include corticosteroids and bronchodilators, which reduce inflammation in the airways. There are also combination inhalers that combine these drugs. Antibiotics, if needed, can also be used to treat bacterial infections.

The global chronic obstructive pulmonary disease (COPD) market focuses on six regions, such as North America, Asia Pacific, South America, Europe, the Middle East, and Africa.

Drivers:

The increasing incidence of chronic obstructive pulmonary disease (COPD) in the world is expected to fuel the growth of the global chronic obstructive pulmonary disease (COPD) market over the forecast period. For instance, according to The Lancet, around 391.9 million individuals in the world, aged 30-79 years of age suffer from COPD. Chronic obstructive pulmonary disease (COPD) can affect any part of the lungs, but the most common symptoms are cough, wheezing, and mucus production. If left untreated, COPD can lead to more serious complications, such as heart problems and respiratory infections. If it is left untreated, COPD can worsen and even lead to death. Chronic bronchitis is another common symptom of COPD. The severity of these symptoms may depend on the individual's lifestyle and the severity of the disease. Moreover, new treatment developments by key players are estimated to enhance the growth of the global chronic obstructive pulmonary disease (COPD) market.

Restraints:

The high cost of treating chronic obstructive pulmonary disease is expected to hinder the growth of the global chronic obstructive pulmonary disease (COPD) market.

Regional Insights:

In regions, North America is expected to dominate the growth of the global chronic obstructive pulmonary disease (COPD) market, owing to the increasing incidence of the disease in the region. For instance, according to the United States Centers for Disease Control and Prevention, COPD affects over 15 million Americans. Moreover, the Asia Pacific is estimated to witness significant growth in the global chronic obstructive pulmonary disease (COPD) market owing to the increasing prevalence of key players in the region, along with the expansion of healthcare facilities.

Competitive Section:

Key players operating in the global chronic obstructive pulmonary disease (COPD) market include Verona Pharmaceuticals, Theravance Biopharma, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals, Inc. (Sumitomo Dainippon Pharma Co., Ltd.), Sanofi, Orion Corporation, Novartis AG, Mylan N.V., Kyowa Hakko Kirin, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., CHIESI Farmaceutici S.p.A., Boehringer Ingelheim International GmbH, AstraZeneca, and Almirall.

In October 2021, the United States gave approval to Mylan Pharmaceuticals for the investigational new drug application (ANDA) called Breyna, which is the first accepted generic version of Symbicort by AstraZeneca.

In January 2019, CHIESI Farmaceutici S.p.A. and TiumBio entered into an agreement.

Chronic Obstructive Pulmonary Disease (COPD) Market Dynamics:

This market study estimates the market size in terms of both value (million USD) and volume (K Units). The Chronic Obstructive Pulmonary Disease (COPD) Market report analyses market trends based on historical data and the latest developments. It provides both qualitative and quantitative data on the elements that will shape the market's growth from 2022 to 2028. The market capacity and consumption potential of major companies are discussed in this research report. Furthermore, it concentrates on prominent regions (Latin America, Europe, Asia Pacific, Africa, and the Middle East). Also, the report evaluates COVID-19's impact on the Chronic Obstructive Pulmonary Disease (COPD) Market.

Companies profiled in the Chronic Obstructive Pulmonary Disease (COPD) Market report include:

  • Abbott (USA)
  • AstraZeneca (UK)
  • Dr. Reddy's Laboratories Ltd (India)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • GSK (UK)
  • Merck (USA)
  • Novartis AG (Switzerland)
  • Pfizer Inc (USA)

The report covers extensive competitive intelligence which includes the following data points:

⇨ Business Overview
⇨ Business Model
⇨ Financial Data
⇨ Financial – Existing
⇨ Financial – Funding
⇨ Product/Service Segment Analysis and specification
⇨ Recent Development and Company Strategy Analysis
⇨ SWOT Analysis

Segmentation by Type:

The type segment contributed the largest share to the Chronic Obstructive Pulmonary Disease (COPD) Market in 2021; this segment is projected to grow at the highest CAGR from 2022 to 2028.

  • Emphysema
  • Chronic Bronchitis

Segmentation by Application:

An end-use industry is projected to grow at the highest CAGR during the forecast period, due to rapid development in emerging economies North America, APAC, MEA, Europe, and ROW.

  • Hospitals & Clinics
  • Home Care Settings
  • others

Key Benefits for Stakeholders:

  1. The study represents a quantitative analysis of the present Chronic Obstructive Pulmonary Disease (COPD) Market trends, estimations, and dynamics of the market size from 2022 to 2028 to determine the most promising opportunities.
  2. Porter's five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
  3. In-depth analysis, as well as market size and segmentation, help you identify current Chronic Obstructive Pulmonary Disease (COPD) Market opportunities.
  4. The largest countries in each region are mapped according to their revenue contribution to the market.
  5. The Chronic Obstructive Pulmonary Disease (COPD) Market research report gives a thorough analysis of the current status of the Chronic Obstructive Pulmonary Disease (COPD) Market's major players.

Reasons to Purchase Chronic Obstructive Pulmonary Disease (COPD) Market Report:

  • Both current and future prospects for the Chronic Obstructive Pulmonary Disease (COPD) Market in developed and emerging markets.
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis.
  • During the forecast period, major regions are expected to see the most rapid increase.
  • Identify the most recent advancements, Chronic Obstructive Pulmonary Disease (COPD) Market shares, and top market players' strategies.

Research Methodology:

To estimate and validate the size of the Chronic Obstructive Pulmonary Disease (COPD) Market and many other dependent submarkets in the overall market, both top-down and bottom-up methodologies are utilized. Key players in the market have been identified through secondary research and their market shares have been determined through primary and secondary research. Secondary sources and verified primary sources were used to determine all percentage share splits and breakdowns.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
    • Stratagem Opportunity Map (SOM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Industry Trends
    • Regulatory Scenario
    • Acquisitions, Partnerships & Agreements
    • Brand Analysis
    • Pricing Analysis
    • Epidemiology
    • Porter’s Analysis
    • Value Chain Analysis
    • Supply Chain Analysis
    • Distribution Landscape
  4. Chronic Obstructive Pulmonary Disease (COPD) Market Market - Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Overall Impact on this Sector
    • Impact of COVID-19 on Supply and Demand
  5. Chronic Obstructive Pulmonary Disease (COPD) Market Market, By Product Type, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2022 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 - 2028
      • Segment Trends
  6. Chronic Obstructive Pulmonary Disease (COPD) Market Market, By Application, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2022 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 - 2028
      • Segment Trends
  7. Chronic Obstructive Pulmonary Disease (COPD) Market Market, By End User, 2017 - 2028 (US$ Million)
    • Introduction
      • Market Share Analysis, 2022 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 - 2028
      • Segment Trends
  8. Competitive Landscape
    • Company Profiles
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
  9. Competitive Landscape
    • Research Methodology
    • About us
    • Contact

* Browse 15 Market Data Tables and 32 Figures on “Chronic Obstructive Pulmonary Disease (COPD) Market Market” – Forecast to 2028.

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.